tiprankstipranks
Effector Therapeutics, Inc. (EFTR)
:EFTR
US Market

eFFECTOR Therapeutics (EFTR) Income Statement

Compare
263 Followers

eFFECTOR Therapeutics Income Statement

Last quarter (Q1 2024), eFFECTOR Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, eFFECTOR Therapeutics's net income was $-8.83M. See eFFECTOR Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 3.55M$ 1.43M$ 42.00M$ 0.00
Gross Profit
$ -22.92M$ 3.50M$ 1.41M$ 20.17M$ -307.00K
Operating Expenses
$ 33.84M$ 32.40M$ 31.90M$ 26.18M$ 28.30M
Depreciation and Amortization
$ 111.00K$ 53.00K$ 24.00K$ 160.00K$ 307.00K
EBITDA
$ -33.73M$ -32.40M$ -31.90M$ 16.05M$ -28.30M
Operating Income
$ -33.84M$ -32.40M$ -31.90M$ 15.82M$ -28.61M
Other Income/Expenses
$ -1.97M$ 9.74M$ 47.70M$ -1.26M$ -1.13M
Pretax Income
$ -35.81M$ -22.66M$ 15.80M$ 14.56M$ -29.74M
Net Income
$ -35.81M$ -12.93M$ 15.80M$ 14.21M$ -29.74M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -16.37$ -7.85$ 9.78$ 23.74$ -53.83
Diluted EPS
$ -16.37$ -7.85$ 9.78$ 23.74$ -53.83
Weighted Average Shares Outstanding
2.19M 1.65M 1.62M 598.56K 552.43K
Weighted Average Shares Outstanding (Diluted)
2.19M 1.65M 1.62M 598.56K 552.43K
Currency in USD

eFFECTOR Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis